(Q48127354)

English

Effects of venlafaxine on extracellular concentrations of 5-HT and noradrenaline in the rat frontal cortex: augmentation via 5-HT1A receptor antagonism.

scientific article published in August 1999

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

8 February 2018

http://europepmc.org/abstract/MED/10462128

Effects of venlafaxine on extracellular concentrations of 5-HT and noradrenaline in the rat frontal cortex: augmentation via 5-HT1A receptor antagonism. (English)

1 reference

Europe PubMed Central

8 February 2018

http://europepmc.org/abstract/MED/10462128

1 reference

based on heuristic

inferred from title

author name string

Dawson LA

1

1 reference

Europe PubMed Central

8 February 2018

http://europepmc.org/abstract/MED/10462128

Nguyen HQ

2

1 reference

Europe PubMed Central

8 February 2018

http://europepmc.org/abstract/MED/10462128

Geiger A

3

1 reference

Europe PubMed Central

8 February 2018

http://europepmc.org/abstract/MED/10462128

publication date

1 August 1999

1 reference

Europe PubMed Central

8 February 2018

http://europepmc.org/abstract/MED/10462128

number of pages

11

1 reference

based on heuristic

inferred from page(s)

Neuropharmacology

1 reference

Europe PubMed Central

8 February 2018

http://europepmc.org/abstract/MED/10462128

38

1 reference

Europe PubMed Central

8 February 2018

http://europepmc.org/abstract/MED/10462128

1153-1163

1 reference

Europe PubMed Central

8 February 2018

http://europepmc.org/abstract/MED/10462128

8

1 reference

Europe PubMed Central

8 February 2018

http://europepmc.org/abstract/MED/10462128

Pindolol Induces a Rapid Improvement of Depressed Patients Treated With Serotonin Reuptake Inhibitors

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2899%2900052-0

7 January 2021

Suppression of firing activity of 5-HT neurons in the dorsal raphe by alpha-adrenoceptor antagonists

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2899%2900052-0

7 January 2021

Blockade of 5-hydroxytryptamine and noradrenaline uptake by venlafaxine: a comparative study with paroxetine and desipramine

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2899%2900052-0

7 January 2021

A randomized, double-blind comparison of a rapidly escalating dose of venlafaxine and imipramine in inpatients with major depression and melancholia

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2899%2900052-0

7 January 2021

Effect of pindolol in hastening response to fluoxetine in the treatment of major depression: a double-blind, placebo-controlled trial

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2899%2900052-0

7 January 2021

Efficacy and tolerability of reboxetine compared with imipramine in a double-blind study in patients suffering from major depressive offsodes

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2899%2900052-0

7 January 2021

Effectiveness of pindolol with selected antidepressant drugs in the treatment of major depression.

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2899%2900052-0

7 January 2021

Selective activation of postsynaptic 5-HT1A receptors induces rapid antidepressant response.

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2899%2900052-0

7 January 2021

Pindolol does not act only on 5-HT1A receptors in augmenting antidepressant activity in the mouse forced swimming test

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2899%2900052-0

7 January 2021

Electrophysiological and neurochemical evidence that pindolol has agonist properties at the 5-HT1A autoreceptor in vivo

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2899%2900052-0

7 January 2021

Differential effects of potassium channel blockers on extracellular concentrations of dopamine and 5-HT in the striatum of conscious rats

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2899%2900052-0

7 January 2021

Effects of 5-HT1A receptor antagonists on fluoxetine-induced changes in extracellular serotonin concentrations in rat frontal cortex.

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2899%2900052-0

7 January 2021

The role of 5-HT(1A) and 5-HT(1B/1D) receptors on the modulation of acute fluoxetine-induced changes in extracellular 5-HT: the mechanism of action of (+/-)pindolol

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2899%2900052-0

7 January 2021

Studies on RX 781094: a selective, potent and specific antagonist of α2-adrenoceptors

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2899%2900052-0

7 January 2021

Serotonin function and the mechanism of antidepressant action. Reversal of antidepressant-induced remission by rapid depletion of plasma tryptophan.

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2899%2900052-0

7 January 2021

Enhancement of fluoxetine-dependent increase of extracellular serotonin (5-HT) levels by (-)-pindolol, an antagonist at 5-HT1A receptors

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2899%2900052-0

7 January 2021

Antagonism of serotonin 5-HT1A receptors potentiates the increases in extracellular monoamines induced by duloxetine in rat hypothalamus.

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2899%2900052-0

7 January 2021

A pharmacological profile of the selective silent 5-HT1A receptor antagonist, WAY-100635

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2899%2900052-0

7 January 2021

Interaction between a selective 5-HT1A receptor antagonist and an SSRI in vivo: effects on 5-HT cell firing and extracellular 5-HT

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2899%2900052-0

7 January 2021

Inhibition of 5-HT cell firing in the DRN by non-selective 5-HT reuptake inhibitors: studies on the role of 5-HT1A autoreceptors and noradrenergic mechanisms.

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2899%2900052-0

7 January 2021

Modulation of the firing activity of noradrenergic neurones in the rat locus coeruleus by the 5-hydroxtryptamine system

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2899%2900052-0

7 January 2021

(-)-Pindolol stereospecifically inhibits rat brain serotonin (5-HT) synthesis.

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2899%2900052-0

7 January 2021

Is pindolol a mixed agonist-antagonist at central serotonin (5-HT) receptors?

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2899%2900052-0

7 January 2021

Serotonin 5-HT1A autoreceptor blockade potentiates the ability of the 5-HT reuptake inhibitor citalopram to increase nerve terminal output of 5-HT in vivo: a microdialysis study.

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2899%2900052-0

7 January 2021

Studies on the role of 5-HT1A autoreceptors and alpha 1-adrenoceptors in the inhibition of 5-HT release--I. BMY7378 and prazosin

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2899%2900052-0

7 January 2021

(-)-Pindolol, but not buspirone, potentiates the citalopram-induced rise in extracellular 5-hydroxytryptamine

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2899%2900052-0

7 January 2021

5-HT1A autoreceptors and the mode of action of selective serotonin reuptake inhibitors (SSRI)

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2899%2900052-0

7 January 2021

WAY100635-induced augmentation of the 5-HT-elevating action of citalopram: relative importance of the dose of the 5-HT1A (auto)receptor blocker versus that of the 5-HT reuptake inhibitor.

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2899%2900052-0

7 January 2021

Pharmacological characterization of selective serotonin reuptake inhibitors (SSRIs).

2 references

https://api.crossref.org/works/10.1016%2FS0028-3908%2899%2900052-0

7 January 2021

https://api.crossref.org/works/10.1016%2FS0028-3908%2899%2900052-0

7 January 2021

based on heuristic

inferred from DOI database lookup

Role of 5-HT1A receptors in the effects of acute chronic fluoxetine on extracellular serotonin in the frontal cortex

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2899%2900052-0

7 January 2021

Venlafaxine exhibits pre-clinical antidepressant activity in the resident-intruder social interaction paradigm.

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2899%2900052-0

7 January 2021

Potentiation of the time-dependent, antidepressant-induced changes in the agonistic behaviour of resident rats by the 5-HT1A receptor antagonist, WAY-100635

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2899%2900052-0

7 January 2021

Antidepressant biochemical profile of the novel bicyclic compound Wy-45,030, an ethyl cyclohexanol derivative

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2899%2900052-0

7 January 2021

A preliminary, open study of the combination of fluoxetine and desipramine for rapid treatment of major depression

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2899%2900052-0

7 January 2021

Augmentation strategies in patients with refractory depression

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2899%2900052-0

7 January 2021

Randomised, double-blind, placebo-controlled trial of pindolol in combination with fluoxetine antidepressant treatment

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2899%2900052-0

7 January 2021

Effect of pindolol on the function of pre- and postsynaptic 5-HT1A receptors: in vivo microdialysis and electrophysiological studies in the rat brain.

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2899%2900052-0

7 January 2021

Increase in extracellular serotonin produced by uptake inhibitors is enhanced after chronic treatment with fluoxetine.

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2899%2900052-0

7 January 2021

5-HT1 agonists reduce 5-hydroxytryptamine release in rat hippocampus in vivo as determined by brain microdialysis.

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2899%2900052-0

7 January 2021

Effect of a selective 5-HT reuptake inhibitor in combination with 5-HT1A and 5-HT1B receptor antagonists on extracellular 5-HT in rat frontal cortex in vivo

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2899%2900052-0

7 January 2021

GR127935: a potent and selective 5-HT1D receptor antagonist

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2899%2900052-0

7 January 2021

Alpha 2-adrenoceptor modulation of rat ventral hippocampal 5-hydroxytryptamine release in vivo

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2899%2900052-0

7 January 2021

Neurochemical evidence that 5-hydroxytryptaminergic neurons tonically inhibit noradrenergic neurons terminating in the hypothalamus.

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2899%2900052-0

7 January 2021

Rapid onset of action of venlafaxine.

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2899%2900052-0

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1016/S0028-3908(99)00052-0

1 reference

Europe PubMed Central

8 February 2018

http://europepmc.org/abstract/MED/10462128

1 reference

Europe PubMed Central

8 February 2018

http://europepmc.org/abstract/MED/10462128

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q48127354&oldid=1786152327"